MOORE DUNCAN enters ALLARITY THERAPEUTICS, INC. with 22.67K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/22/2021ACC: 0001213900-21-067026
22.67K
Baseline shares
100% direct
22.67K
Direct ownership
1 position
41.99K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, $0.0001
DirectShares owned22.67K
Total
22.67K direct22.67K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 | 22.67K | Direct |
| Total | 22.67K | 22.67K direct |
Derivative Holdings1
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
41.99K
Shares owned
N/A
Exercise price
10.11
Expiration
—
Exercise window
—
Total
Underlying
41.99K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 10.11 | — | — | 41.99K | N/A |
| Total | 41.99K | 0.00 | ||||